BRIEF published on 12/11/2025 at 10:10, 8 months 15 days ago Novarc successfully completes the offer to acquire MADE shares Share Buyback Euronext Access NOVARC Stock Market Delisting MADE SA
BRIEF published on 10/31/2025 at 12:20, 9 months 26 days ago Correction to the timetable for NOVARC's takeover bid for MADE Euronext Buyback Offer Revised Calendar MADE NOVARC
BRIEF published on 10/30/2025 at 08:05, 9 months 27 days ago MADE offers to take over and delist its shares Buyback Offer Euronext Access NOVARC MADE Actions Stock Market Delisting
BRIEF published on 09/25/2025 at 18:05, 11 months 1 day ago Major acquisition of MADE by NOVARC Acquisition Buyback Offer Euronext Access MADE NOVARC
BRIEF published on 08/01/2025 at 18:05, 1 year ago MADE: Signing of an agreement for a majority sale to NOVARC Actions Euronext Access MADE Assignment NOVARC
Published on 08/27/2026 at 00:05, 1 hour 37 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 2 hours 42 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 3 hours 12 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 3 hours 12 minutes ago Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 4 hours 27 minutes ago Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 23:05, 2 hours 37 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 6 hours 58 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 7 hours 2 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 7 hours 12 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 7 hours 42 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 18:02, 7 hours 40 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 7 hours 42 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 7 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 7 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
